Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in relapsed/refractory TTP-HUS
NCT00531089Phase 2Unknown
- Sponsor
- Hamilton Health Sciences
- Start
- Dec 2007
- Primary completion
- Jan 2011
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), sponsored by Hamilton Health Sciences. Status: unknown.
02
Drugs
rituximab
03
Conditions
thrombotic thrombocytopenic purpura (TTP)hemolytic uremic syndrome (HUS)
Beyond the preview
Go deeper on NCT00531089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531089.